The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Larger Will The Neurocognitive Assessment And Rehabilitation Market Become By 2030 Compared To 2026?
The neurocognitive assessment and rehabilitation market has seen strong growth in recent years. This market is expected to expand from $14.65 billion in 2025 to $16.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. The historical increase can be ascribed to factors such as the rising incidence of cognitive impairment disorders, the early uptake of standardized neurocognitive tests, the proliferation of hospital-based rehabilitation initiatives, greater recognition of neurological assessment, and the development of paper-based cognitive testing approaches.
The neurocognitive assessment and rehabilitation market size is anticipated to experience robust growth in the upcoming years. It is projected to reach $22.02 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. The expansion during the forecast period can be attributed to factors such as the proliferation of digital cognitive testing platforms, the increasing adoption of VR-based rehabilitation therapy, the growing implementation of AI-enabled assessment software, a rising demand for homecare cognitive therapy solutions, and the advancement of sophisticated neuromodulation devices. Noteworthy trends for the forecast period include a greater embrace of computerized cognitive assessment tools, a surging demand for virtual reality-based rehabilitation, the wider use of standardized neuropsychological tests, the expansion of neurofeedback and TMS-based therapy, and an increasing preference for home-based cognitive rehabilitation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15870&type=smp
Which Core Factors Are Supporting The Expansion Of The Neurocognitive Assessment And Rehabilitation Market?
The increasing occurrence of neurological disorders is anticipated to propel the growth of the neurocognitive assessment and rehabilitation market in the future. Neurological disorders are health conditions that impact the nervous system, encompassing the brain, spinal cord, and nerves, leading to symptoms such as muscle weakness, problems with coordination, and cognitive impairments. These disorders can be attributed to a combination of factors, including an aging population and the widespread incidence of age-related conditions like Alzheimer’s disease and Parkinson’s disease. Neurocognitive assessment provides valuable insights into cognitive function, assisting in the diagnosis and treatment planning for neurological disorders, while rehabilitation interventions aim to optimize neural functioning and enhance quality of life through targeted therapies and strategies. As an example, in October 2023, according to the World Federation of Neurology, a UK-based charity, neurological disorders currently represent the second-leading cause of death and the primary cause of disability worldwide, reflecting an accelerating global health burden. More than 40 percent of the global population was affected in 2023, and the number of individuals living with brain disease is projected to nearly double by 2050. Therefore, the rising prevalence of neurological disorders is a key factor driving the growth of the neurocognitive assessment and rehabilitation market.
How Is The Neurocognitive Assessment And Rehabilitation Market Structured Across Different Market Segments?
The neurocognitive assessment and rehabilitation market covered in this report is segmented –
1) By Components: Neurocognitive Assessment Testing, Neurorehabilitation Therapy
2) By Providers: Rehab Centers, Hospital And Clinics, Homecare Settings, Physiotherapy Centers
3) By Organization Size: Large Enterprises, Small And Medium-Sized Enterprises (SMEs)
Subsegments:
1) By Neurocognitive Assessment Testing: Standardized Tests, Computerized Neurocognitive Assessments, Paper-Based Neurocognitive Tests
2) By Neurorehabilitation Therapy: Cognitive Behavioral Therapy (CBT), Virtual Reality Therapy, Transcranial Magnetic Stimulation (TMS), Neurofeedback Therapy, Physical Therapy And Occupational Therapy
Which Trends Are Influencing The Expansion Of The Neurocognitive Assessment And Rehabilitation Market?
Major companies active in the neuroblastoma market are prioritizing the development of advanced therapeutic interventions, such as humanized anti-GD2 monoclonal antibodies, with the goal of more effectively and safely targeting and treating cancer cells. A humanized anti-GD2 monoclonal antibody is engineered to specifically target the GD2 molecule on cancer cells, aiming to reduce immune rejection by incorporating human components. For instance, in August 2023, Renaissance Pharma Ltd., a UK-based clinical-stage pharmaceutical firm, announced it had in-licensed Hu14.18K322A (Hu14.18) from St. Jude Children’s Research Hospital. This antibody is intended for the treatment of newly diagnosed high-risk neuroblastoma, which is a rare and aggressive cancer affecting children. Under the terms of the agreement, Renaissance has secured exclusive rights to develop, manufacture, and commercialize Hu14.18 across crucial global markets, including the United States, Canada, Europe, China, Japan, and Turkey.
Who Are The Companies Shaping The Neurocognitive Assessment And Rehabilitation Market Landscape?
Major companies operating in the neurocognitive assessment and rehabilitation market are Cogstate Ltd, Posit Science Corporation, Lumos Labs Inc., The Magstim Company Ltd, MindMaze SA, CogniFit Inc, Cambridge Cognition Holdings plc, ImPACT Applications Inc., Neurotrack Technologies Inc., Neuroelectrics Corporation, SCHUHFRIED GmbH, Constant Therapy Health Inc., NeuronUP S.L., Qbtech AB, Neurometrix Inc., CogniVue Corporation, Neurohealth Associates LLP, BrainTrain Inc., NeuroEM Therapeutics Inc., HASOMED GmbH, Neurosoft Bioelectronics Corporation, AnthroTronix Inc., Flow Neuroscience AB, NPsych Limited
Access The Complete Neurocognitive Assessment And Rehabilitation Market Report:
Which Area Represents The Largest Portion Of The Neurocognitive Assessment And Rehabilitation Market?
North America was the largest region in the neurocognitive assessment and rehabilitation market in 2025. The regions covered in the neurocognitive assessment and rehabilitation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Neurocognitive Assessment And Rehabilitation Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=15870&type=smp
Browse Through More Reports Similar to the Global Neurocognitive Assessment And Rehabilitation Market 2026, By The Business Research Company
Neurostimulation Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
Neurodegenerative Disorder Therapeutic Global Market Report 2026
Brain And Neuroimaging Devices Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
